STING pathway modulator - Txinno Bioscience
Latest Information Update: 24 Aug 2023
At a glance
- Originator Txinno Bioscience
- Developer Korea Research Institute of Chemical Technology; Txinno Bioscience
- Class Antineoplastics; Small molecules
- Mechanism of Action MPYS protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer
Most Recent Events
- 24 Jul 2023 Early research in Cancer in South Korea (unspecified route) (Txinno Bioscience pipeline, July 2023)